v3.26.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 12 Months Ended 21 Months Ended
Sep. 17, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 18, 2019
Defined Benefit Plan Disclosure [Line Items]        
Number of shares, granted   100,000  
Exercise price   $ 0.63 $ 0.51  
Stock-based compensation expense   $ 126,578 $ 992,735  
Deferred compensation expense   $ 2,087,605    
Weighted average term   2 years 21 days    
Aggregate intrinsic value   $ 0.30    
Number of shares, exercised   550,000 450,000  
Number of shares, vested   1,605,000    
Chief Executive Officer [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Shares options expiration description the Company’s Board of Directors adopted resolutions to extend D, Sean McEwen’s expiration dates on his last two (2) 187,500 share option tranches by one (1) year, or to respectively expire at midnight on September 17, 2025, and December 17, 2025.      
Number of shares, exercised   375,000 375,000  
One Independent [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Number of shares, exercised     75,000  
Two Independent [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Number of shares, exercised   125,000    
One Former Independent [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Number of shares, exercised   50,000    
Majority Shareholder [Member]        
Defined Benefit Plan Disclosure [Line Items]        
Merge consideration shares       13,500,000
Number of shares, granted       1,500,000
Exercise price       $ 0.22